Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 394 of 5804
-
New hope for advanced lung cancer: experimental drug takes on chemo in major trial
Disease control Recruiting nowThe purpose of this study is to understand if PF-08046054 alone works well compared to standard-of-care docetaxel alone in participants with non-small cell lung cancer (NSCLC) with PD-L1 expression greater than or equal to 1% and had cancer progression during or after treatment w…
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Gene therapy trial targets tough T-Cell cancers
Disease control Recruiting nowBackground: Chemokine receptor 4 (CCR4) is a protein that is found on the surface of certain T-cell lymphoma cells and is common in mature T-cell cancers. White blood cells can be changed with molecules called anti-CCR4 to express a chimeric antigen receptors (CAR), which is a m…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug trial aims to tame gut disease in kids
Disease control Recruiting nowThe aim of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of filgotinib as a treatment for UC in children and adolescents aged from 8 to less than 18 years. Approximately 80 subjects from 8 to \<18 years of age with moderately to severely…
Phase: PHASE3 • Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New vaccine aims to stop pneumococcal bacteria in Kids' noses
⭐️ VACCINE ⭐️ Recruiting nowThe goal of this clinical trial is to evaluate whether the wSp vaccine can prevent nasopharyngeal colonization by pneumococcal bacteria in healthy young children who have received routine PCV15 or PCV20 vaccination. The main questions it aims to answer are: Does wSp vaccine red…
Phase: PHASE2 • Sponsor: Serum Life Science Europe GmbH • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:00 UTC
-
Engineered immune cells take on sarcoma in early trial
Disease control Recruiting nowTo find a recommended dose of attIL2-TIL cell therapy that can be given to participant with either relapsed or metastatic sarcomas (has come back or spread to other parts of the body, respectively). To further test the dose found in Part A to see if it can help to control liposa…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New chemo combo shows promise for tough pancreatic tumors
Disease control Recruiting nowThe purpose of this research is to study the effects and safety of alternating neoadjuvant chemotherapy on borderline resectable pancreatic cancer.
Phase: PHASE2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
AI-Powered navigation aims to boost colon cancer screening in 45-49 year olds
Prevention ENROLLING_BY_INVITATIONThis project aims to use machine learning algorithms (MLA) to identify and risk-stratify individuals between the ages of 45-49 who are more likely to have colorectal pathology and merit prioritized CRC screening and patient navigation. Patients deemed to be at higher risk for CRC…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Gene-Tailored therapy could be Game-Changer for rare cancer patients
Knowledge-focused Recruiting nowRare cancers, defined by an incidence of fewer than 6 cases per 100,000 persons per year, constitute nearly 25% of adult malignancies. They are associated with poor patient outcomes due to incomplete biological understanding and inadequate representation in clinical trials. To ad…
Sponsor: German Cancer Research Center • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Could a milk protein help ICU patients survive?
Disease control CompletedIntroduction: Lactoferrin has several uses due to its effects. It has anti-inflammatory, antioxidant, immunomodulatory, antibacterial, antifungal, and antiviral effects. Its safety is proven by food and drug administration. Aims: The objective is to study the effect of lactofe…
Phase: PHASE4 • Sponsor: Mansoura University Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New hope for ulcerative colitis patients who failed other treatments
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy of RO7837195 compared with placebo in participants with moderately to severely active ulcerative colitis for whom prior treatment with conventional and/or advanced therapies has failed.
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Softer breathing aid could spare preemies from harsh ventilators
Symptom relief Recruiting nowPreterm babies often have trouble breathing because their lungs are not fully developed. This condition is called respiratory distress syndrome (RDS). A medicine called surfactant helps their lungs open up and work better. It is usually given through a procedure called INSURE, wh…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Urine test may spare bladder cancer patients from unnecessary second surgery
Diagnosis Recruiting nowNon-muscle-invasive bladder cancer (NMIBC) accounts for approximately 75% of newly diagnosed bladder cancers and is characterized by a high risk of recurrence and progression. Current guidelines recommend that patients with stage T1 NMIBC undergo a second transurethral resection …
Phase: NA • Sponsor: Tianjin Medical University Second Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
New prostate cancer combo aims to delay disease worsening
Disease control Recruiting nowThis study will explore whether a combination of the investigational drug mevrometostat (PF-06821497) and enzalutamide will work better than taking enzalutamide alone in participants with mCSPC who are ARPI naïve and have not yet received chemotherapy in the mCSPC setting.
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New pill aims to tame rare inflammatory disease
Disease control Recruiting nowThis is a Phase 3, parallel group, 2-arm, randomized, double blind, placebo-controlled, 52-week treatment study to assess the efficacy and safety of rilzabrutinib as a treatment for adult patients with active IgG4-RD. The purpose of this study is to measure time to IgG4-RD clini…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New hope for kids with tough cancers: targeted radiation trial launches
Disease control Recruiting nowThe purpose of the study is to determine the appropriate pediatric dosage and evaluate the pharmacokinetics (PK) and safety of Lutetium Lu 177 Edotreotide Targeted Radiopharmaceutical Therapy (RPT) as a monotherapy or following standard of care (SoC) in participants ≥2 to \<18 ye…
Phase: PHASE1 • Sponsor: ITM Solucin GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for older AML patients: shorter, safer transplant strategy
Disease control Recruiting nowThis phase II trial tests the safety, side effects, and how well combination chemotherapy with fludarabine, high-dose cytarabine, granulocyte colony-stimulating factor (G-CSF), and idarubicin (FLAG-Ida) followed immediately by reduced-intensity total body radiation therapy, calle…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New hope for advanced bladder cancer patients who have run out of options
Disease control Recruiting nowThis is a global, multicenter, randomized, open-label, Phase 2/3 study of Dato-DXd plus carboplatin or cisplatin versus gemcitabine plus carboplatin or cisplatin in participants with la/mUC who progressed during or after EV plus pembrolizumab combination treatment. This trial wi…
Phase: PHASE2, PHASE3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Immunotherapy plus chemo may turn inoperable esophageal cancer into surgical candidates
Disease control Recruiting nowThis is a Phase II, open-label, single-arm, multicenter study evaluating the safety and efficacy of combining Tislelizumab with induction chemoradiotherapy (CRT), followed by conversion surgery, in patients with locally advanced, unresectable esophageal squamous cell carcinoma (E…
Phase: PHASE2 • Sponsor: Ming-Yu Lien • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Pulse radiation may supercharge immunotherapy against cancer
Disease control Recruiting nowThe goal of this clinical trial is to find out whether Adaptive Pulse Radiotherapy (Pulse RT) combined with immune checkpoint inhibitors (ICIs) helps treat advanced solid tumors. It will also check how safe this combined treatment is and how it affects the immune system and qual…
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a cystic fibrosis drug help brain bleed survivors walk again?
Disease control Recruiting nowSubarachnoid hemorrhage due to aneurysm rupture (SAH) results in high mortality, while survivors frequently suffer reduced quality of life and even loss of autonomy, particularly in the active population. A significant proportion of this morbidity and mortality is linked to the o…
Phase: PHASE2 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC